Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Feb 02, 2018 11:53am
36 Views
Post# 27490139

RE:RE:RE:RE:RE:TLT

RE:RE:RE:RE:RE:TLTIndeed u are the fool, not talking about our results, our science! of course pharma would balk if it was only about CHRONIC KNEE PAIN! BUT IT AINT CHUMP!! AND DO U THINK, PHARMA DOESNT HAVE THEIR GAGGLE OF LAWYERS AND IN THEIR BID, CLAUSES WILL BE INCLUDED THAT WILL try to CONTROL THE MOM AND POP BEHAVIOUR THEY SEE GOING ON, BUT ARE WILLING TO WORK WITH BECAUSE THEY HAVE BEEN FORCED TO BID NOW because they see and realize the importance of A SCIENCE WITH SO MUCH PROMISE????? So, yasufukkkkkinmoron, pharma , in their bid, will have some clauses to be considered and wil cause , Nr Part Trois. Tlt is pleased to announce that the number and complexity of the bids requires greater scrutiny, and in that regard the final decision for a jv has been pushed back to June 15!!!!!!! Then our share price goes over 30 dollars!!! Its about the hype, yaz you know what hype is, that thing that has been missing here for over 12 months, that thing that a ceo is supposed to be in front of, that thing that make sp pop, that thing that start the buzz!!!! Its about our science, our results, and why they have been muzzled!!! quote=bionicjoe]Macman1519, if you think about it a PP appears to be RW's only alternative. You are asking big pharma to bankroll TLT but if the management is as untrustworthy as you have made them out to be, would big pharma want to get involved? Consider too that half their $5 million a year losses are directly tied to their pain therapy division. Would big pharma want to use their money to support the sale and distribution of a machine used to treat knee pain? If you go to TLT's website you'll see a sizable gaggle of people needing to be paid for their services. Big pharma money might hesitate having to pay for that crowd. It's unlikely RW would allow them to cherry pick where their money goes. If it was just for cancer research then what about the pain therapy division? Hold a PP just for the TLC-2000? Unlikely.  [/quote]

Bullboard Posts